Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory Factors
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This study was conducted to demonstrate superiority of nateglinide in postprandial glucose
fluctuation, dyslipidemia, and inflammatory status improvement.